Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer

MLA

Katherine A. Michaelis, et al. “Publisher Correction: The TLR7/8 Agonist R848 Remodels Tumor and Host Responses to Promote Survival in Pancreatic Cancer.” Nature Communications, vol. 10, no. 1, Nov. 2019, p. 1. EBSCOhost, https://doi.org/10.1038/s41467-019-13151-z.

APA

Katherine A. Michaelis, Mason A. Norgard, Xinxia Zhu, Peter R. Levasseur, Shamilene Sivagnanam, Shannon M. Liudahl, Kevin G. Burfeind, Brennan Olson, Katherine R. Pelz, Diana M. Angeles Ramos, H. Carlo Maurer, Kenneth P. Olive, Lisa M. Coussens, Terry K. Morgan, & Daniel L. Marks. (2019). Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. Nature Communications, 10(1), 1. https://doi.org/10.1038/s41467-019-13151-z

Chicago

Katherine A. Michaelis, Mason A. Norgard, Xinxia Zhu, Peter R. Levasseur, Shamilene Sivagnanam, Shannon M. Liudahl, Kevin G. Burfeind, et al. 2019. “Publisher Correction: The TLR7/8 Agonist R848 Remodels Tumor and Host Responses to Promote Survival in Pancreatic Cancer.” Nature Communications 10 (1): 1. doi:10.1038/s41467-019-13151-z.